The DES Center

Filter Your Results

 

News

 

STOPDAPT-2 Data Show Improved Outcomes for Stent Patients on a P2Y12 Inhibitor Who Stop Taking Aspirin After 1 Month

March 18, 2019 -- Data from the STOPDAPT-2 trial show that patients who stopped taking aspirin 1 month after undergoing coronary stenting but continued taking a P2Y12 inhibito…

Biotronik Launches Orsiro DES With Presentations of Data at CRT

March 6, 2019 -- Biotronik announced that 3-year outcomes from the BIO-RESORT randomized controlled trial were presented by Clemens von Birgelen, MD, as late-breaking clinical…

FDA Approval Expands Indication for Medtronic's Resolute DES to Treat De Novo CTO

February 26, 2019 -- Medtronic announced FDA approval of an expanded indication for its Resolute drug-eluting stent (DES) platform for the treatment of patients with coronary …

Study Compares Biosensors' BioFreedom DES and Alvimedica's Cre8 DES in Italian Registries

February 25, 2019 -- A study published by Mauro Chiarito, MD, et al in Circulation: Cardiovascular Interventions demonstrated that the polymer-free BioFreedom biolimus-eluting…

FDA Approves Biotronik's Ultrathin Orsiro DES for the Treatment of Coronary Artery Disease

February 22, 2019 -- Biotronik announced FDA approval of the Orsiro drug-eluting stent (DES) system, which is now available commercially in the United States for use in percut…

Study Reports Long‐Term Follow‐Up of Covered Stent Implantation for Various Coronary Artery Diseases

February 19, 2019 -- In Catheterization and Cardiovascular Interventions (CCI), Daisuke Hachinohe, MD, et al published long‐term follow‐up findings from a study of coronar…

Alvimedica’s 2-mm Cre8 Evo DES Receives CE Mark Approval

February 4, 2019 -- Alvimedica announced European CE Mark approval of its 2-mm Cre8 EVO drug-eluting stent, further enlarging the company's polymer-free, amphilimus-eluting st…

SCAI Issues Statement on the Association of Paclitaxel Devices and Mortality

January 25, 2019 -- The Society for Cardiovascular Angiography and Interventions (SCAI) has issued a statement on the recent study of the association between paclitaxel-elutin…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.